Business
Press Release Aug 30 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 30, 2023, titled "Strides receives USFDA approval for Mycophenolate Mofetil for Oral Suspension".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 30, 2023, titled "Strides receives USFDA approval for Mycophenolate Mofetil for Oral Suspension". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd